Free Trial
NYSE:OSTX

OS Therapies (OSTX) Stock Price, News & Analysis

OS Therapies logo
$1.73 -0.02 (-1.14%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.72 -0.01 (-0.52%)
As of 08/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About OS Therapies Stock (NYSE:OSTX)

Key Stats

Today's Range
$1.68
$1.79
50-Day Range
$1.56
$1.98
52-Week Range
$1.12
$7.00
Volume
404,504 shs
Average Volume
738,270 shs
Market Capitalization
$48.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

OS Therapies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

OSTX MarketRank™: 

OS Therapies scored higher than 49% of companies evaluated by MarketBeat, and ranked 561st out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OS Therapies has received a consensus rating of Buy. The company's average rating score is 3.40, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    OS Therapies has only been the subject of 1 research reports in the past 90 days.

  • Read more about OS Therapies' stock forecast and price target.
  • Earnings Growth

    Earnings for OS Therapies are expected to grow in the coming year, from ($0.64) to ($0.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OS Therapies is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OS Therapies is -2.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for OSTX.
  • Dividend Yield

    OS Therapies does not currently pay a dividend.

  • Dividend Growth

    OS Therapies does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for OSTX.
  • News Sentiment

    OS Therapies has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for OS Therapies this week, compared to 2 articles on an average week.
  • Search Interest

    19 people have searched for OSTX on MarketBeat in the last 30 days. This is an increase of 19% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added OS Therapies to their MarketBeat watchlist in the last 30 days. This is an increase of 83% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OS Therapies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.80% of the stock of OS Therapies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about OS Therapies' insider trading history.
Receive OSTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter.

OSTX Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
OS Therapies Inc News (OSTX) - Investing.com
See More Headlines

OSTX Stock Analysis - Frequently Asked Questions

OS Therapies' stock was trading at $4.28 at the beginning of the year. Since then, OSTX shares have decreased by 59.6% and is now trading at $1.73.

OS Therapies (OSTX) raised $8 million in an IPO on Thursday, August 1st 2024. The company issued 2,000,000 shares at $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) served as the underwriter for the IPO.

Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX).

Company Calendar

Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:OSTX
Previous Symbol
NYSE:OSTX
CIK
1795091
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$20.00
Low Price Target
$15.00
Potential Upside/Downside
+940.5%
Consensus Rating
Buy
Rating Score (0-4)
3.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-569.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.76
Quick Ratio
0.76

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,098,000
Free Float
N/A
Market Cap
$48.61 million
Optionable
N/A
Beta
N/A

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:OSTX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners